EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin‐Induced Sporadic Alzheimer’s Disease in Mice

Oxidative Medicine And Cellular Longevity

Oxidative Medicine and Cellular Longevity · 2026-01 · 2026 (1)

DOI: 10.1155/omcl/9795039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oxidative Medicine and Cellular Longevity, online erschienen am 28.10.2026. Verfasst von Oxidative Medicine And Cellular Longevity. Die Arbeit nennt 1 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cellular Longevity, O. M. A. (2026). RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin‐Induced Sporadic Alzheimer’s Disease in Mice. Oxidative Medicine and Cellular Longevity, 2026(1). https://doi.org/10.1155/omcl/9795039

Vancouver

Cellular Longevity OMA. RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin‐Induced Sporadic Alzheimer’s Disease in Mice. Oxidative Medicine and Cellular Longevity. 2026;2026(1). doi:10.1155/omcl/9795039

BibTeX
@article{CellularLongevity2026,
  author = {Cellular Longevity, Oxidative Medicine And},
  title = {RETRACTION: Probiotics Fermentation Technology, a Novel Kefir Product, Ameliorates Cognitive Impairment in Streptozotocin‐Induced Sporadic Alzheimer’s Disease in Mice},
  journal = {Oxidative Medicine and Cellular Longevity},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/omcl/9795039}
}
Kostenlos starten →